We determined PLD3, DNMT3B, and ZEB1 expression levels in 30 cases of primary breast cancer and the paired adjacent normal tissues, which results showed that PLD3 expression was lower in breast cancer tissues compared to normal breast tissue, while DNMT3B and ZEB1 expression were higher in breast cancer tissues (Fig. 7A). This evidence concerns the gene DNMT3B and breast carcinoma.